2. Amyotrophic lateral sclerosis Clinical trials / Disease details

Clinical trials : 645 / Drugs : 589 - (DrugBank : 163) / Drug target genes : 150 - Drug target pathways : 225

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03377309 (ClinicalTrials.gov)	December 1, 2019	14/12/2017	Safety and Tolerability of Perampanel in Amyotrophic Lateral Sclerosis Patients	Safety and Tolerability of Perampanel in Amyotrophic Lateral Sclerosis Patients	Amyotrophic Lateral Sclerosis	Drug: Fycompa	American University of Beirut Medical Center	NULL	Terminated	18 Years	80 Years	All	6	Phase 2	Lebanon
2	NCT03020797 (ClinicalTrials.gov)	January 12, 2017	15/12/2016	A Clinical Trial to Evaluate the Safety and Efficacy of Fycompa in Subjects With Amyotrophic Lateral Sclerosis (ALS)		Amyotrophic Lateral Sclerosis	Drug: Perampanel;Drug: Placebo Oral Tablet	Stony Brook University	Eisai Inc.	Recruiting	18 Years	80 Years	All	60	N/A	United States